32ACTIVITIES
2ORGS REPRESENTED
2BILLS
Organizations represented
2Orgs whose LD-2 filings list Matthew as an active lobbyist, sorted by activity volume.
Topics in Filings
30Policy topics Matthew files on across all their LD-2 activities.
Pharmacy benefit manager reform×12
General education about policies×10
Impacting pharmaceutical development, approval and reimbursement×10
Rebates for Medicare Part D×8
Importation. 340B Program×8
Show all 30 topics (+25 more) ▾
Drug pricing×8
Prescription drug pricing issues, particularly related to MFN×6
Potential tariff actions under Section 232 of the Trade Act×6
IPI drug pricing proposal×4
Medicare Rebate Rule×4
Impacting Medicare Part D×4
Part B and 340 B programs×4
IP Protections related to trade agreements×4
Trade policies×4
Impacting pharmaceutical development×4
Legislative proposals related to WTO TRIPS Waiver×4
Drug pricing proposals×4
P.L. 119-21×4
Drug safety and drug counterfeiting×2
Drug importation×2
340B program×2
Proposals, issues×2
Tax issues×2
Affecting the pharmaceutical industry including international tax×2
Vaccine excise tax issues×2
Medicare payment issues×2
Medicare Part D×2
Protecting Seniors Through Immunization Act×2
Support for immunization access, access to migraine screening×2
Support for tick-borne disease research and womens health×2
Pulled from the org’s own LD-2 disclosures. See the source filings ↓
Issue mix
LDA general-issue codes weighted by activity count.
Medicare/Medicaid6
Health Issues6
Budget/Appropriations6
Defense6
Trade (domestic/foreign)6
Taxation/Internal Revenue Code2